133 related articles for article (PubMed ID: 3535009)
1. Colicinogeny in chronic inflammatory bowel disease.
Bures J; Horák V; Buresová E; Fixa B; Komárková O; Hartmann M
Scand J Gastroenterol; 1986 Sep; 21(7):819-23. PubMed ID: 3535009
[TBL] [Abstract][Full Text] [Related]
2. [Colicinogeny in nonspecific intestinal inflammations and colorectal cancer].
Bures J; Horák V; Tichý M; Pidrman V; Jandík P; Fixa B; Komárková O
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1991; 34(3):349-403. PubMed ID: 1819866
[TBL] [Abstract][Full Text] [Related]
3. [Colicinogens in nonspecific intestinal inflammations. II. Test of leukocyte migration inhibition with colicins].
Bures J; Horák V; Buresová E; Fixa B; Komárková O
Cesk Gastroenterol Vyz; 1983 Apr; 37(3):186-90. PubMed ID: 6347404
[No Abstract] [Full Text] [Related]
4. Cellular hypersensitivity to components of intestinal mucosa in ulcerative colitis and Crohn's disease.
Bendixen G
Gut; 1969 Aug; 10(8):631-6. PubMed ID: 5810973
[TBL] [Abstract][Full Text] [Related]
5. Leukocyte migration test in Crohn's disease, ulcerative colitis, and ankylosing spondylitis using Crohn's colon homogenate, mitochondrial, and microsomal fractions.
Williams MJ; Richens ER; Gough KR; Ancill RJ
Am J Dig Dis; 1975 May; 20(5):425-9. PubMed ID: 1130367
[TBL] [Abstract][Full Text] [Related]
6. [Colicinogens in nonspecific intestinal inflammation. I. Colicinotypes in patients with ulcerous colitis, Crohn's disease and in healthy individuals].
Bures J; Horák V; Buresová E; Fixa B; Komárková O
Cesk Gastroenterol Vyz; 1983 Mar; 37(2):81-6. PubMed ID: 6342822
[No Abstract] [Full Text] [Related]
7. Escherichia coli isolates from patients with inflammatory bowel disease: ExPEC virulence- and colicin-determinants are more frequent compared to healthy controls.
Micenková L; Frankovičová L; Jaborníková I; Bosák J; Dítě P; Šmarda J; Vrba M; Ševčíková A; Kmeťová M; Šmajs D
Int J Med Microbiol; 2018 Jul; 308(5):498-504. PubMed ID: 29735381
[TBL] [Abstract][Full Text] [Related]
8. Cellular and humoral response to Kunin antigen (CA) in ulcerative colitis and Crohn's disease.
Bartnik W; Kałuzewski S
Arch Immunol Ther Exp (Warsz); 1979; 27(4):531-8. PubMed ID: 518259
[TBL] [Abstract][Full Text] [Related]
9. Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease.
Giaffer MH; Holdsworth CD; Duerden BI
Gut; 1992 May; 33(5):646-50. PubMed ID: 1612481
[TBL] [Abstract][Full Text] [Related]
10. Use of Escherichia coli Nissle 1917 producing recombinant colicins for treatment of IBD patients.
Kotłowski R
Med Hypotheses; 2016 Aug; 93():8-10. PubMed ID: 27372848
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of atopy is unrelated to presence of inflammatory bowel disease.
Troncone R; Merrett TG; Ferguson A
Clin Allergy; 1988 Mar; 18(2):111-7. PubMed ID: 3365856
[TBL] [Abstract][Full Text] [Related]
12. Chlamydia trachomatis and inflammatory bowel disease--a coincidence?
Orda R; Samra Z; Levy Y; Shperber Y; Scapa E
J R Soc Med; 1990 Jan; 83(1):15-7. PubMed ID: 2304046
[TBL] [Abstract][Full Text] [Related]
13. [Virus, Crohn's disease, ulcerative colitis and non-specific enterocolitis].
Poynard T; Girard-Pipau F; Pérol Y
Gastroenterol Clin Biol; 1981 May; 5(5):537-53. PubMed ID: 7018982
[No Abstract] [Full Text] [Related]
14. Transmissible agents in inflammatory bowel disease: 1980.
Beeken WL
Med Clin North Am; 1980 Nov; 64(6):1021-35. PubMed ID: 7007757
[No Abstract] [Full Text] [Related]
15. [Presence of intracellular Escherichia coli in patients with inflammatory bowel disease].
De La Fuente M; Chahuán I; Gutiérrez R; Díaz-Jiménez D; Olivares M; Vidal R; Simian D; Figueroa C; Quera R; Hermoso MA
Rev Med Chil; 2017 Sep; 145(9):1129-1136. PubMed ID: 29424399
[TBL] [Abstract][Full Text] [Related]
16. The role of infection in the aetiology of inflammatory bowel disease.
Hansen R; Thomson JM; El-Omar EM; Hold GL
J Gastroenterol; 2010 Mar; 45(3):266-76. PubMed ID: 20076977
[TBL] [Abstract][Full Text] [Related]
17. Atopy in inflammatory bowel disease.
Mee AS; Brown D; Jewell DP
Scand J Gastroenterol; 1979; 14(6):743-6. PubMed ID: 531506
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory bowel disease: progress and current concepts of etiopathogenesis.
Scaldaferri F; Fiocchi C
J Dig Dis; 2007 Nov; 8(4):171-8. PubMed ID: 17970872
[TBL] [Abstract][Full Text] [Related]
19. The immunology of chronic ulcerative colitis and Crohn's disease.
Shorter RG; Tomasi TB; Huizenga KA; Spencer RJ; Stobo JD
Ann N Y Acad Sci; 1976; 278():586-91. PubMed ID: 786126
[No Abstract] [Full Text] [Related]
20. In-vitro inhibition of leucocyte migration in Crohn's disease by a sarcoid spleen suspension.
Willoughby JM; Mitchell DN
Br Med J; 1971 Jul; 3(5767):155-7. PubMed ID: 5557864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
